Delivery Order SPE2DB20D1100-SPE2DB23FD8F7
Award Date
9/25/23
Potential Completion Date
9/26/23
Potential Value
$46K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product LAMICTAL 150 MG TABLET 60S. The contract has a potential value of $1,211.96 and a performance period through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,082.36 with a completion date of October 23, 2023. The contract is for the supply of LAMICTAL 150 MG TABLET 60S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,069.63, is a delivery order for the supply of LAMICTAL 150 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price arrangement. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,549.68 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,702.34 Firm Fixed Price Delivery Order contract covers the supply of LAMICTAL 150 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,444.83 issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of LAMICTAL 200 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The IDC has a $999,999,999 ceiling value and runs through November 2026, serving as a primary vehicle for Amerisourcebergen to provide a comprehensive range...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,220.88, is for the delivery of Lamictal 150 mg tablets and has an ultimate completion date of April 7, 2023. The contract type is a delivery order with a firm fixed price pricing structure. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Lamictal 25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,797.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 21, 2024 and is a delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen maintains a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.56, is for the delivery of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,802.36 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of January 24, 2025 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...